🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

May the joy and wonder of Christmas fill your hearts with hope. Happy Holidays, from program director, Doug Simonetto, MD and the Gastroenterology Fellows

Happy to share with you our review on ALCOHOL-ASSOCIATED HEPATITIS, published today in the NEJM. We dedicate it to all our patients. We will continue to work together to beat it. Vijay Shah Juan Pablo (JP) Arab, MD  bit.ly/3jBU16R #LiverTwitter #MedTwitter

I used to joke with my father (a surgeon) over how Gi will eventually take over his bread&butter cases (CCY and appi’s) First EUS-GB drainage and now ERAT for appendicitis.. 👀 RCT 👇🏻 Mohamed Othman Haris Rashid Shaikh #Gitwitter #endoscopy #MedTwitter onlinelibrary.wiley.com/doi/10.1111/17…

My favorite people in AI to follow, the reason to follow them & their top tweet:

Dream team of collaborators! Great perspective! Pranav Rajpurkar Matthew Lungren MD MPH

Big problem journals.lww.com/hepcomm/Fullte… #livertwitter

💡Wondered about how to best allocate non-directed living liver donations? ➡️ check out our model to identify potential recipients based on predicted graft survival! UWGASTRO Liver/Intestinal Community of Practice - AST #ldlt #MachineLearning frontiersin.org/articles/10.33…

📑 Alcohol-associated Hepatitis incidence is 📈 at an alarming rate! Disproportionate 📈 especially among women and individuals of low socioeconomic status‼️🚨 #LiverTwitter #OpenAccess journals.lww.com/hepcomm/Fullte…

MAESTRO-NASH is a positive trial Resmetirom improved NASH resolution and reduced fibrosis at 52-weeks. It is safe. Is it a landmark study? Yes Will it change NASH? Depends on cost, adherence in real world, and effect on clinical outcomes #EASLCongress #LiverTwitter

Our Ramon Bataller inspiring the young generation with the state of the art lecture in #ALD #LiverTwitter #EASLCongress EASL Education EASLnews Luis Antonio Díaz, MD David Marti Aguado Joaquin Cabezas Global AlcHep - A BigData Network

#EASL2023 was a blast because I got to meet my heroes, mentors, collaborators, and friends all in the course of a few days while learning about the latest breakthroughs in our field. Definitely leaving inspired.

Please join us in celebrating our 2023 Transplant Hepatology graduates! We wish you all the best!!! Robert Huebert Joseph C. Ahn, M.D. Bilal Asif, MD Vivian Ortiz Nandan Parthasarathy

Today’s #readoftheweek📚 explores how MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis. Read here this🔓 #openaccess JHEP Reports article: bit.ly/3qzMmKm 🙏 Luis Antonio Díaz, MD Francisco Idalsoaga MD